Completely Intraureteral Stents Decrease Urinary Symptoms Compared to Conventional Ureteral Stents: A Systematic Review And Meta-Analysis

David E. Hinojosa-Gonzalez,Gal Saffati,Shane Kronstedt,Richard Edward Link,Wesley Adam Mayer

DOI: https://doi.org/10.1089/end.2023.0467

2024-01-09

Journal of Endourology

Abstract:Introduction: Up to 80% of stent patients report urinary discomfort, negatively impacting their daily activities and quality of life. Conventional double-J ureteral stents (DJS) can cause adverse kidney and bladder-related symptoms. Completely intraureteral stents (CIS) may reduce bothersome bladder symptoms by reducing foreign material in the bladder. We sought to aggregate and analyze ureteral stent symptom questionnaire (USSQ) data from the available randomized controlled trials comparing CIS with conventional ureteral stents. Methods: In February 2023, a PRISMA-compliant systematic review was performed to identify studies that evaluated the use of CIS and reported outcomes using the USSQ score. Two authors (DH and GS) independently extracted and analyzed data using Review Manager 5.41. Heterogeneity was assessed using Higgins I2%, with values over 50% considered heterogeneous and analyzed with a random effects model; otherwise, a fixed effects model was used. The results are presented as the Mean Difference (MD) with 95% confidence intervals. We set our significance level at P = 0.05. Results: Six randomized controlled clinical trials compared CIS with DJSs, but only five trials reported the USSQ score. Among these patients, 235 had CIS, while the remaining 259 had DJS or Loop-tail Stents and served as controls for 494 patients. Urinary Symptoms scores were lower in the CIS group (MD -5.19, 95% CI: [-5.89,-4.50], p<0.0001). Pain scores were also lower in the CIS group (MD -1.90[-2.63,-1.16] p<0.00001). General Health and Work Performance domains were similar between the groups. A 2.5% stent failure or migration rate requiring endoscopic intervention was reported in the CIS group compared to 0.3% in the DJS group (OR 4.01[0.96,16.76] p=0.06). Conclusions: Completely intraureteral stents significantly decrease urinary symptoms and pain associated with conventional indwelling ureteral stents. However, further trials are needed to determine the optimal patient selection for this type of stent.

urology & nephrology